Nevertheless, our findings did reveal a decline in TUBA1B expression with increasing stages of COAD patients, suggesting that TUBA1B may serve as a promising early diagnostic marker for COAD, even though its prognostic value requires further investigation in future studies. This evidence concerns the gene TUBA1B and colon adenocarcinoma.